| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 11 763-772, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
A Batova, D Danielpour, L Pirisi and KE Creek
Department of Chemistry and Biochemistry, University of South Carolina, Columbia 29208.
Similar cellular responses are elicited by retinoic acid (RA) and transforming growth factor beta (TGF-beta). We investigated the ability of RA to modulate the production of TGF-beta in normal human keratinocytes (HKc) and HKc lines immortalized by transfection with human papillomavirus type 16 DNA (HKc/HPV16). RA treatment of both normal HKc and HKc/HPV16 resulted in a 2-3-fold induction in secreted levels of latent TGF-beta. The induction in TGF-beta secretion by RA was dose dependent, with significant increases observed with RA concentrations as low as 1-10 nM, and time dependent, with maximal induction occurring about 3 days after initiation of RA exposure. In addition, RA induced intracellular levels of TGF-beta almost 5-fold. Sandwich enzyme-linked immunosorbent assays were used to specifically quantify TGF-beta 1 and TGF-beta 2 secreted by normal HKc and HKc/HPV16 cultured in the absence or presence of RA. RA increased the secreted levels of latent TGF-beta 1 and TGF-beta 2 an average of 2- and 5-fold, respectively, with no major differences in the fold induction between normal HKc and HKc/HPV16. Northern blot analysis of mRNA isolated from HKc/HPV16 demonstrated that RA treatment induced specific transcripts for TGF-beta 1 and TGF-beta 2 about 3- and 50-fold, respectively. RA treatment of HKc had no significant effect on the binding affinity of TGF-beta for its receptors or receptor number. Normal HKc and HKc/HPV16 displayed similar dose-dependent inhibition of proliferation by TGF-beta 1. These studies indicate that RA may regulate growth control in both normal HKc and HKc/HPV16 by enhancing TGF-beta 1 and TGF-beta 2 production, which, after activation at the cell surface, could inhibit cellular proliferation in an autocrine and/or paracrine manner.
This article has been cited by other articles:
![]() |
F. Chen, T. J. Desai, J. Qian, K. Niederreither, J. Lu, and W. V. Cardoso Inhibition of Tgf{beta} signaling by endogenous retinoic acid is essential for primary lung bud induction Development, August 15, 2007; 134(16): 2969 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nees, J. M. Geoghegan, P. Munson, V. Prabhu, Y. Liu, E. Androphy, and C. D. Woodworth Human Papillomavirus Type 16 E6 and E7 Proteins Inhibit Differentiation-dependent Expression of Transforming Growth Factor-{beta}2 in Cervical Keratinocytes Cancer Res., August 1, 2000; 60(15): 4289 - 4298. [Abstract] [Full Text] |
||||
![]() |
X.-C. Xu, M. F. Mitchell, E. Silva, A. Jetten, and R. Lotan Decreased Expression of Retinoic Acid Receptors, Transforming Growth Factor {beta}, Involucrin, and Cornifin in Cervical Intraepithelial Neoplasia Clin. Cancer Res., June 1, 1999; 5(6): 1503 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Agarwal, A. Lambert, R. A.S. Chandraratna, E. A. Rorke, and R. L. Eckert Vitamin D Regulates Human Ectocervical Epithelial Cell Proliferation and Insulin-Like Growth Factor-Binding Protein-3 Level Biol Reprod, March 1, 1999; 60(3): 567 - 572. [Abstract] [Full Text] |
||||
![]() |
G.-R. Han, D. F. Dohi, H.-Y. Lee, R. Rajah, G. L. Walsh, W. K. Hong, P. Cohen, and J. M. Kurie All-trans-retinoic Acid Increases Transforming Growth Factor-beta 2 and Insulin-like Growth Factor Binding Protein-3 Expression through a Retinoic Acid Receptor-alpha -dependent Signaling Pathway J. Biol. Chem., May 23, 1997; 272(21): 13711 - 13716. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |